EFFICIENCY, SAFETY AND UNWARRANTED POLYPHARMACY IN THE TREATMENT OF ACUTE RESPIRATORY DISEASES

Download full text PDF
Issue: 
11
Year: 
2016

V. Shishkova, Candidate of Medical Sciences Center for Speech Pathology and Neurorehabilitation, Moscow

In certain seasons, the population and clinicians traditionally show an increasing interest in the use of anti-influenza or cold remedies, mainly antiviral, immunotropic, and symptomatic agents. The abundance of these medications, most of them over-the-counter ones, hinders their right choice.
Keywords: 
infectious diseases
acute respiratory viral infections
influenza
prevention
safety

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. The world health report 2002 – Reducing Risks, Promoting Healthy Life // World Health Organization. – 2002; 186: 192.
  2. Rothberg M., Haessler S., Brown R. Complications of viral influenza // Am. J. Med. – 2008; 121 (4): 258–64.
  3. Dvoretskij L.I. Lechenie bol'nyh ostrymi respiratornymi zabolevanijami: est' li al'ternativa polipragmazii? // Consillium Medicum. – 2008; 10 (10): 10–4.
  4. Kljuchnikov S.O. Polipragmazija: puti reshenija problemy // Detskie infektsii. – 2014; 4: 36–41.
  5. Jefferson T., Jones M., Doshi P. et al. Neuraminidase inhibitors for preventing and treating influenza in adults and children // Cochrane Database Syst. Rev. – 2014; 4: CD008965. DOI: 10.1002/14651858.CD008965.pub4.
  6. Jefferson T., Jones M., Doshi P. et al. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments // BMJ. – 2014; 348: g2545. doi: http://dx.doi.org/10.1136/bmj.g2545 (Published 09 April 2014)
  7. http://www.whocc.no/atc_ddd_index/code=J05AX
  8. Leneva I.A., Fedjakina I.T., Eropkin M.Ju. i dr. Izuchenie protivovirusnoj aktivnosti otechestvennyh protivogrippoznyh himiopreparatov v kul'ture kletok i na modeli zhivotnyh // Vopr. virusol. – 2010; 3:19–25.
  9. Lombardo F., Waters N., Argikar U. et al. Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance // J. Clin. Pharmacol. – 2013; 53 (2): 178–91.
  10. Berry L., Li C., Zhao Z. Species differences in distribution and prediction of human V(ss) from preclinical data // Drug Metab. Dispos. – 2011; 39 (11): 2103–16.
  11. Kolobukhina L., Merkulova L., Shchelkanov M. et al. Efficacy of ingavirin in adults with influenza // Ter. Arkh. – 2009; 81 (3): 51–4.
  12. Svistushkin V.M., Nikiforova G.N., Vlasova N.P. Vozmozhnosti lechenija bol'nyh s ostrymi respiratornymi virusnymi infektsijami v nastojaschee vremja // Lechaschij vrach. – 2013; 1: 2–5.
  13. Haria M., Benfield P. Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis // Drugs. – 1995; 50 (5): 873–96.
  14. Sbornik nauchnyh statej po osnovam gomeopatii i gomeopaticheskim preparatam / M., 2001.
  15. Gomeopatija v XXI veke: vozmozhnosti i perspektivy // Meditsinskij sovet. – 2016; 16: 38–42.
  16. Marrari L., Terzan L., Chaufferin G. Oscillococcinum for influenza treatment // Ann. Ist. Super Sanita. – 2012; 48 (1): 105–9.
  17. Beghi G., Morselli-Labate A. Does homeopathic medicine have a preventive effect on respiratory tract infections? A real life observational study // Multidiscip. Respir. Med. – 2016; 11: 12.
  18. 18. Mathie R., Frye J., Fisher P. Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness // Cochrane Database Syst. Rev. – 2015; 1: CD001957.
  19. Kovalenko L.P., Tollerova A.V., Kuzntsova O.S. i dr. Eksperimental'noe izuchenie allergizirujuschih svojstv i immunotoksichnosti preparata Otsillokoktsinum // Toksikol. vestn. – 2015; 1 (130): 37–41.
  20. Sel'kova E.P., Volchetskij A.L., Lapitskaja A.S. i dr. Vlijanie Otsillokotsinuma na interferon obrazovanie u chasto bolejuschih detej // Consilium Medicum. Pediatrija. – 2009; 4: 42–7.
  21. Egorov V.I., Kozarenko A.V. Sovremennyj podhod k lecheniju ostryh virusnyh rinosinusitov // Al'manah klinicheskoj meditsiny. – 2016; 44 (7).
  22. Geppe N.A., Krylova N.A., Tjurina E.N. i dr. Napravlenie sovershenstvovanija terapii ORVI u detej // Doktor.Ru. – 2016; 6 (123): 47–51.
  23. Samsygina G.A. i dr. Novye tehnologii v profilaktike ostryh respiratornyh infektsij i grippa u detej mladshego vozrasta // Pediatrija. – 2008; 5 (87).
  24. Sel'kova E.P., Lapitskaja A.C., Oganesjan A.S. i dr. Izuchenie kliniko-epidemiologicheskoj effektivnosti gomeopaticheskogo preparata pri grippe i ORVI // Infekts. bolezni. – 2012; 10 (3): 83–9.
  25. Papp P., Shubak P., Bek E. et al. // Britich Homoeopathik Journal. – 1998; 87: 69–76.
  26. Kazjukova T.V., Radtsig E.Ju., Pankratov I.V. i dr. Sravnitel'naja otsenka effektivnosti dvuh protivovirusnyh preparatov v lechenii grippa i ORVI u detej 6–12 let // Pediatrija. – 2015; 6: 105–12.